Harbour BioMed and Evinova Partner to Advance AI-Driven Biologics Development
Harbour BioMed (HBM), a global biopharmaceutical company focused on innovative antibody therapeutics in immunology and oncology, has entered into a strategic collaboration with Evinova, a global health-tech company dedicated to advancing digital health solutions for the life sciences sector.
Evinova | 10/11/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy